Fact CheckerSign in

NCT07871565Completed

Time-Restricted Eating With or Without Energy Restriction in Dyslipidemic Women With Owerweight or Obesity

Time-Restricted Eating With or Without Energy Restriction in Dyslipidemic Women With Owerweight or Obesity: An 8-Week Three-Arm Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

Background/Objectives: It is unclear whether the effects of time-restricted eating (TRE) on body composition and blood lipids are independent of energy restriction (ER), and whether combining the two confers additional benefit. Methods: In this prospective, 8-week, three-arm, parallel-group randomized controlled trial, 85 sedentary women aged 19-65 years with overweight/obesity and untreated dyslipidemia were allocated to TRE (16:8, ad libitum intake within a 12:00-20:00 window), ER (individually calculated diet providing approximately 500 kcal/day below total energy expenditure) or TRE + ER. Anthropometry and bioelectrical impedance analysis were performed at baseline, week 4 and week 8, and fasting biochemistry at baseline and week 8.

Status (registry)
Completed
Study type
Interventional
Enrollment
56 (actual)
First submitted
16 Sept 2026
Start date
1 Feb 2022
Primary completion date
30 Jul 2024
Lead sponsor
Acibadem University
Diseases
Obesity
NCT number
NCT07871565

What you commit to

  • Study type: Interventional
  • Participants enrolled: 56
  • From 1 Feb 2022 to the primary completion date, 30 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • a major adverse cardiovascular event in the previous year (acute coronary syndrome, percutaneous coronary interven-tion, coronary artery bypass grafting, hospitalization for congestive heart failure, stroke or transient ischemic attack)
  • any concurrent medical nutrition therapy prescribed for another indication (e.g., celiac disease)
  • previous bariatric surgery
  • thyroid disease requiring dose titration of replacement therapy within the previous three months (stable replacement therapy for hypothyroidism was not an exclusion criterion)

Other illness

  • uncontrolled arrhythmia
  • diabetes mellitus or reactive hypo-glycemia
  • congenital or immunological disease
  • acute pancreatitis, cirrhosis or malignancy
  • a diagnosed eating disorder
  • stage 4 or 5 chronic kidney disease or dialysis treatment
  • a major psychiatric disorder.

Other

  • Pregnancy or lactation
  • Shift work
  • smoking
  • excessive alcohol consumption

Who the study is looking for

  • Eligible participants were sedentary women aged 19-65 years with overweight or obesity (BMI ≥ 25 kg/m²) who had received a physician diagnosis of dyslipidemia but were not taking lipid-lowering medication, and who volunteered to take part.

Age in the registry: 19 years to 65 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Acibadem University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.